$0.77
-0.0352[-4.37%]
At close: May 17
$0.77
0[0.00%]
After Hours: 5:53PM EDT
Cara Therapeutics: Insider buying and selling updated today.
May 06, 2024 | Christopher Posner | PRESIDENT AND CEO | -3.936K | $0.75 | -$2.95K | SELL | -2.18% | 176.585K | May 02 | View |
Apr 09, 2024 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.753K | $0.83 | -$2.28K | SELL | -4.91% | 53.365K | Apr 05 | View |
Apr 09, 2024 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.753K | $0.83 | -$2.28K | SELL | -3.03% | 88.247K | Apr 05 | View |
Mar 04, 2024 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -3.293K | $0.89 | -$2.93K | SELL | -3.49% | 91K | Feb 29 | View |
Mar 04, 2024 | Christopher Posner | PRESIDENT AND CEO | -5.834K | $0.89 | -$5.19K | SELL | -3.13% | 180.521K | Feb 29 | View |
Mar 04, 2024 | Joana Goncalves | CHIEF MEDICAL OFFICER | -3.293K | $0.89 | -$2.93K | SELL | -5.54% | 56.118K | Feb 29 | View |
Feb 12, 2024 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -7.77K | $0.53 | -$4.12K | SELL | -7.61% | 94.293K | Feb 08 | View |
Feb 12, 2024 | Ryan Maynard | CHIEF FINANCIAL OFFICER | -5.488K | $0.53 | -$2.91K | SELL | -40.65% | 8.012K | Feb 08 | View |
Feb 12, 2024 | Joana Goncalves | CHIEF MEDICAL OFFICER | -7.77K | $0.53 | -$4.12K | SELL | -11.57% | 59.411K | Feb 08 | View |
Feb 12, 2024 | Christopher Posner | PRESIDENT AND CEO | -35.575K | $0.53 | -$18.85K | SELL | -16.03% | 186.355K | Feb 08 | View |
Feb 05, 2024 | Christopher Posner | PRESIDENT AND CEO | 57.519K | $0.55 | -$2.74K | GRANT | 34.98% | 221.93K | Feb 01 | View |
Nov 03, 2023 | Christopher Posner | PRESIDENT AND CEO | -3.796K | $1.22 | -$4.63K | SELL | -2.26% | 164.411K | Nov 02 | View |
Aug 04, 2023 | Christopher Posner | PRESIDENT AND CEO | -4.307K | $3.07 | -$13.22K | SELL | -2.50% | 168.207K | Aug 03 | View |
Jun 27, 2023 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.483K | $3.51 | -$8.72K | SELL | -2.73% | 88.563K | Jun 23 | View |
Jun 27, 2023 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -2.993K | $3.51 | -$10.51K | SELL | -1.91% | 153.747K | Jun 23 | View |
Jun 27, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.723K | $3.51 | -$9.56K | SELL | -4.83% | 53.681K | Jun 23 | View |
May 09, 2023 | Christopher Posner | PRESIDENT AND CEO | -3.869K | $4.40 | -$17.02K | SELL | -2.19% | 172.514K | May 05 | View |
Apr 06, 2023 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.481K | $4.91 | -$12.18K | SELL | -2.65% | 91.046K | Apr 04 | View |
Apr 06, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.481K | $4.91 | -$12.18K | SELL | -4.21% | 56.404K | Apr 04 | View |
Apr 06, 2023 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -2.733K | $4.91 | -$13.42K | SELL | -1.71% | 156.74K | Apr 04 | View |
Mar 07, 2023 | Christopher Posner | PRESIDENT AND CEO | -5.987K | $9.71 | -$58.13K | SELL | -3.28% | 176.383K | Mar 03 | View |
Mar 07, 2023 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -6.802K | $9.71 | -$66.05K | SELL | -4.09% | 159.473K | Mar 03 | View |
Mar 07, 2023 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -6.256K | $9.71 | -$60.75K | SELL | -6.27% | 93.527K | Mar 03 | View |
Mar 07, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -6.221K | $9.71 | -$60.41K | SELL | -9.56% | 58.885K | Mar 03 | View |
Feb 17, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.265K | $10.20 | -$23.10K | SELL | -3.36% | 65.106K | Feb 16 | View |
Feb 03, 2023 | Christopher Posner | PRESIDENT AND CEO | -4.191K | $11.80 | -$49.45K | SELL | -2.25% | 182.37K | Feb 02 | View |
Jan 19, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.265K | $10.81 | -$24.48K | SELL | -3.25% | 67.371K | Jan 17 | View |
Jan 03, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.265K | $10.18 | -$23.06K | SELL | -3.15% | 69.636K | Dec 29 | View |
Dec 23, 2022 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -3.506K | $11.27 | -$39.51K | SELL | -2.07% | 166.275K | Dec 21 | View |
Dec 23, 2022 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.992K | $11.27 | -$33.72K | SELL | -4.00% | 71.901K | Dec 21 | View |
Browse insider trades on all stocks.